For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250123:nRSW3650Ua&default-theme=true
RNS Number : 3650U Judges Scientific PLC 23 January 2025
23 January 2025
Judges Scientific plc
("Judges Scientific" or the "Company")
Grant of Options
Judges Scientific announces that it has issued options over 76,500 new
ordinary shares of 5 pence each in the Company ("Ordinary Shares") at an
exercise price per share of £76.90, being the closing mid-price on 22
January 2025.
76,500 options have been awarded in total by the Remuneration Committee to
certain of the Directors, as shown in the table below, to retain and
incentivise them. Vesting of the options after three years is subject to the
achievement of 5% compound growth in adjusted earnings per share over the
vesting period, and to continued employment.
Director Number of options Option Scheme Vesting date Expiry date
Tim Prestidge 60,000 Unapproved 23/01/2028 22/01/2035
David Cicurel 5,500 Unapproved 23/01/2028 22/01/2035
Brad Ormsby 5,500 Unapproved 23/01/2028 22/01/2035
Mark Lavelle 5,500 Unapproved 23/01/2028 22/01/2035
The Remuneration Committee seeks through its award of share options to
motivate, retain and incentivise executives of the calibre that will grow
shareholder value successfully. The share option awards align the interests
of executives and shareholders. Tim Prestidge, Group Business Development
Director, has been issued additional options as his original share options
from the time of his appointment, which were granted on 31 March 2023, were
issued with a 10% compound growth rate, prior to the enactment of the increase
in UK corporation tax from 19% to 25%. In this context, the Remuneration
Committee consider such compound performance target to be overly ambitious for
the vesting period.
Further it is noted that the Company erroneously omitted disclosing the issue
of share options to Ian Wilcock, Group Commercial Director, when he joined the
Company. The award of options, which was made on 19 September 2024, is
summarised below.
Director Number of options Exercise price Option Scheme Vesting date Expiry date
Ian Wilcock 305 £98.30 Approved 19/09/2027 19/09/2034
Ian Wilcock 29,695 £98.30 Unapproved 19/09/2027 19/09/2034
For further information please contact:
Judges Scientific plc Shore Capital (Nominated Adviser & Joint Broker)
David Cicurel, CEO Stephane Auton
Brad Ormsby, CFO Harry Davies-Ball
Tel: +44 (0) 20 3829 6970 Tel: +44 (0) 20 7408 4090
Liberum (Joint Broker) Investec Bank plc (Joint Broker)
Edward Mansfield Virginia Bull
Nikhil Varghese Carlton Nelson
Joshua Borlant Tel: +44 (0) 207 597 4000
Tel : +44 (0) 20 3100 2222
Alma (Financial Public Relations)
Sam Modlin
Rebecca Sanders-Hewett
Joe Pederzolli
Sarah Peters
Tel: +44 (0) 20 3405 0205
judges@almastrategic.com
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and
developing companies in the scientific instrument sector. The Group consists
of 25 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to
a diverse range of markets including: higher education institutions,
scientific research facilities, manufacturers and regulatory authorities.
The UK is a recognised centre of excellence for scientific instruments. The
Group has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long
term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that
generate sustainable profits and cash. Shareholder returns are created through
the reduction of debt, organic growth and dividends.
For further information, please visit www.judges.uk.com
(https://www.judges.uk.com/)
Judges Scientific plc
Director/PDMR Shareholding
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name David Cicurel
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Judges Scientific plc
b) LEI 2138004EXWWPTW1JOL31
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in Judges Scientific plc
Identification code
GB0032398678
b) Nature of the transaction Grant of Options
c) Price(s) and volume(s)
Price(s) Volume(s)
7690p 5,500
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
e) Date of the transaction 23/01/2025
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
23/01/2025
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
Judges Scientific plc
Director/PDMR Shareholding
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Bradley Ormsby
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Judges Scientific plc
b) LEI 2138004EXWWPTW1JOL31
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in Judges Scientific plc
Identification code
GB0032398678
b) Nature of the transaction Grant of Options
c) Price(s) and volume(s)
Price(s) Volume(s)
7690p 5,500
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
e) Date of the transaction 23/01/2025
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
23/01/2025
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
Judges Scientific plc
Director/PDMR Shareholding
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Mark Lavelle
2 Reason for the notification
a) Position/status Chief Operating Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Judges Scientific plc
b) LEI 2138004EXWWPTW1JOL31
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in Judges Scientific plc
Identification code
GB0032398678
b) Nature of the transaction Grant of Options
c) Price(s) and volume(s)
Price(s) Volume(s)
7690p 5,500
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
e) Date of the transaction 23/01/2025
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
23/01/2025
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
Judges Scientific plc
Director/PDMR Shareholding
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Tim Prestidge
2 Reason for the notification
a) Position/status Group Business Development Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Judges Scientific plc
b) LEI 2138004EXWWPTW1JOL31
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in Judges Scientific plc
Identification code
GB0032398678
b) Nature of the transaction Grant of Options
c) Price(s) and volume(s)
Price(s) Volume(s)
7690p 60,000
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
e) Date of the transaction 23/01/2025
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
23/01/2025
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
Judges Scientific plc
Director/PDMR Shareholding
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Ian Wilcock
2 Reason for the notification
a) Position/status Group Commercial Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Judges Scientific plc
b) LEI 2138004EXWWPTW1JOL31
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in Judges Scientific plc
Identification code
GB0032398678
b) Nature of the transaction Grant of Options
c) Price(s) and volume(s)
Price(s) Volume(s)
9830p 30,000
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
e) Date of the transaction 19/09/2024
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
19/09/2024
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHDGGDBLBDDGUD